• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Pediatr . Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of COVID-19

tetano

Editor, Senior Moderator
World J Pediatr


. 2022 Mar 14.
doi: 10.1007/s12519-022-00529-1. Online ahead of print.
Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of COVID-19


Jing Hao[SUP] 1 [/SUP], Xiao-Chen Hu[SUP] 1 [/SUP], Ming-Xing Fan[SUP] 1 [/SUP], Jun Chen[SUP] 1 [/SUP], Qi-Rui Cheng[SUP] 1 [/SUP], Zhuo Li[SUP] 2 [/SUP], Zhi-Liang Hu[SUP] 3 [/SUP], Xu-Hua Ge[SUP] 4 [/SUP]



Affiliations

Abstract

Background: The aim of this study was to analyze the clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of coronavirus disease 2019 (COVID-19).
Methods: Sixty-six pediatric patients with B.1.617.2 (Delta) variant of COVID-19 admitted to the hospital from July to August 2021 were classified into mild (n = 41) and moderate groups (n = 25). Clinical characteristics, laboratory data and dynamic trends in different time periods were analyzed retrospectively.
Results: There were no statistically significant differences in age, gender ratios and clinical symptoms between the mild group and the moderate group. All the patients in the moderate group had clusters of onsets, and the incubation period was shorter than that of the mild group. Within 24 hours of admission, the levels of erythrocyte sedimentation rate, cardiac troponin I, D-dimer in the moderate group were higher than that in the mild group (P < 0.05). The titers of immunoglobulin (Ig) G and IgM antibodies gradually increased after disease onset. Thirty-five (53.03%) children were tested positive for antibodies in 4-12 days. IgG increased gradually, while IgM decreased obviously in about 15 days after disease onset. The cycle threshold values of open reading frame 1ab and nucleocapsid protein gene in the severe acute respiratory syndrome coronavirus 2 genomes increased gradually on the 3rd, 6th, 9th, and 12th days after disease onset, compared with those in day 0.
Conclusions: The symptoms of children with B.1.617.2 (Delta) variant of COVID-19 were mild. The description and analysis of the clinical characteristics and laboratory data can help medical staff to evaluate the condition of children with COVID-19 and to accumulate more clinical experience.

Keywords: B.1.617.2 (Delta); Children; Clinical features; Coronavirus disease 2019 (COVID-19).
 
Back
Top Bottom